Plain-English translation of NCT07550140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand whether ETAS®, a supplement, can help older adults who notice mild changes in memory or thinking skills. Over 12 weeks, you'll take either the real medication or a placebo (a dummy capsule that looks identical), and researchers will measure changes in your thinking, mood, sleep, and brain activity using brain scans and cognitive tests.
As we age, many people experience mild changes in memory and thinking that aren't yet diagnosed as disease. This medication may help protect brain health and mental well-being, but that hasn't been thoroughly studied yet—so this trial will test whether it actually works.
You likely qualify if…
You likely don't qualify if…
You will visit the research center before and after the 12-week study period for brain scans, cognitive tests (thinking and memory tasks), mood and sleep questionnaires, and basic measurements like blood pressure and waist circumference. Between visits, you'll take one capsule by mouth each day for 12 weeks—either the real medication or placebo. Some participants will also collect a stool sample at home so researchers can study gut bacteria.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
United Kingdom
Sponsor
University of Reading
Collaborators
Amino Up Chemicals Co., Ltd.
Enrollment target
~60 participants
Started
May 2026
Primary completion
December 2027
Age range
60 Years – 80 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Piril Hepsomali, PhD
University of Reading
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.